Phio Pharmaceuticals Corp.
PHIO
$2.09
$0.020.97%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 1.07M | 15.00K | 985.00K | 644.00K | 866.00K |
| Gross Profit | -1.07M | -15.00K | -985.00K | -644.00K | -866.00K |
| SG&A Expenses | 1.24M | 986.00K | 689.00K | 946.00K | 1.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.31M | 1.87M | 1.67M | 1.59M | 1.91M |
| Operating Income | -2.31M | -1.87M | -1.67M | -1.59M | -1.91M |
| Income Before Tax | -2.17M | -1.77M | -1.63M | -1.52M | -1.85M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.17M | -1.77M | -1.63M | -1.52M | -1.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.17M | -1.77M | -1.63M | -1.52M | -1.85M |
| EBIT | -2.31M | -1.87M | -1.67M | -1.59M | -1.91M |
| EBITDA | -2.31M | -1.87M | -1.67M | -1.59M | -1.91M |
| EPS Basic | -0.45 | -0.41 | -1.43 | -1.54 | -3.62 |
| Normalized Basic EPS | -0.28 | -0.26 | -0.89 | -0.96 | -2.26 |
| EPS Diluted | -0.45 | -0.41 | -1.43 | -1.54 | -3.62 |
| Normalized Diluted EPS | -0.28 | -0.26 | -0.89 | -0.96 | -2.26 |
| Average Basic Shares Outstanding | 4.79M | 4.31M | 1.14M | 990.00K | 510.20K |
| Average Diluted Shares Outstanding | 4.79M | 4.31M | 1.14M | 990.00K | 510.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |